144 related articles for article (PubMed ID: 8689632)
1. Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells.
el-akawi Z; Abu-hadid M; Perez R; Glavy J; Zdanowicz J; Creaven PJ; Pendyala L
Cancer Lett; 1996 Jul; 105(1):5-14. PubMed ID: 8689632
[TBL] [Abstract][Full Text] [Related]
2. Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line.
el-akawi Z; Zdanowicz J; Creaven PJ; Abu-hadid M; Perez R; Pendyala L
Oncol Res; 1996; 8(10-11):415-23. PubMed ID: 9114434
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780/C10.
Hector S; Nava ME; Clark K; Murphy M; Pendyala L
Cancer Lett; 2007 Jan; 245(1-2):195-204. PubMed ID: 16516375
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies on the mechanisms of oxaliplatin resistance.
Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of gamma-glutamylcysteine synthetase activity in melphalan-resistant human multiple myeloma cells expressing increased glutathione levels.
Mulcahy RT; Bailey HH; Gipp JJ
Cancer Chemother Pharmacol; 1994; 34(1):67-71. PubMed ID: 7513621
[TBL] [Abstract][Full Text] [Related]
6. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
7. Gamma-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer.
Kigawa J; Minagawa Y; Cheng X; Terakawa N
Clin Cancer Res; 1998 Jul; 4(7):1737-41. PubMed ID: 9676849
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of glutathione by oxidants and dexamethasone in alveolar epithelial cells.
Rahman I; Bel A; Mulier B; Donaldson K; MacNee W
Am J Physiol; 1998 Jul; 275(1):L80-6. PubMed ID: 9688938
[TBL] [Abstract][Full Text] [Related]
9. Enhanced gamma-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity.
Das GC; Bacsi A; Shrivastav M; Hazra TK; Boldogh I
Mol Carcinog; 2006 Sep; 45(9):635-47. PubMed ID: 16491484
[TBL] [Abstract][Full Text] [Related]
10. Enteral nutrition and keratinocyte growth factor regulate expression of glutathione-related enzyme messenger RNAs in rat intestine.
Jonas CR; Farrell CL; Scully S; Eli A; EstÃvariz CF; Gu LH; Jones DP; Ziegler TR
JPEN J Parenter Enteral Nutr; 2000; 24(2):67-75. PubMed ID: 10772185
[TBL] [Abstract][Full Text] [Related]
11. Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.
Yao KS; Godwin AK; Johnson SW; Ozols RF; O'Dwyer PJ; Hamilton TC
Cancer Res; 1995 Oct; 55(19):4367-74. PubMed ID: 7671249
[TBL] [Abstract][Full Text] [Related]
12. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
Yao K; Godwin AK; Ozols RF; Hamilton TC; O'Dwyer PJ
Cancer Res; 1993 Aug; 53(16):3662-6. PubMed ID: 8101766
[TBL] [Abstract][Full Text] [Related]
13. The cell-specific anti-proliferative effect of reduced glutathione is mediated by gamma-glutamyl transpeptidase-dependent extracellular pro-oxidant reactions.
Perego P; Paolicchi A; Tongiani R; Pompella A; Tonarelli P; Carenini N; Romanelli S; Zunino F
Int J Cancer; 1997 Apr; 71(2):246-50. PubMed ID: 9139850
[TBL] [Abstract][Full Text] [Related]
14. gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents.
Ahmad S; Okine L; Wood R; Aljian J; Vistica DT
J Cell Physiol; 1987 May; 131(2):240-6. PubMed ID: 2884224
[TBL] [Abstract][Full Text] [Related]
15. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
Tew KD; Monks A; Barone L; Rosser D; Akerman G; Montali JA; Wheatley JB; Schmidt DE
Mol Pharmacol; 1996 Jul; 50(1):149-59. PubMed ID: 8700107
[TBL] [Abstract][Full Text] [Related]
16. Increase in gamma-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels.
Bailey HH; Gipp JJ; Ripple M; Wilding G; Mulcahy RT
Cancer Res; 1992 Sep; 52(18):5115-8. PubMed ID: 1355406
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of cyanohydroxybutene on glutathione synthesis in liver and pancreas of male rats.
Davis MA; Wallig MA; Eaton D; Borroz KI; Jeffery EH
Toxicol Appl Pharmacol; 1993 Dec; 123(2):257-64. PubMed ID: 7902618
[TBL] [Abstract][Full Text] [Related]
18. Glutathione metabolic status in the aged rabbit aorta.
Lapenna D; Ciofani G; Giamberardino MA
Exp Gerontol; 2017 May; 91():34-38. PubMed ID: 28188813
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.
Goto S; Yoshida K; Morikawa T; Urata Y; Suzuki K; Kondo T
Cancer Res; 1995 Oct; 55(19):4297-301. PubMed ID: 7671239
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.
Mulcahy RT; Untawale S; Gipp JJ
Mol Pharmacol; 1994 Nov; 46(5):909-14. PubMed ID: 7969079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
